Robert Wasserman's Stock Ratings

Benchmark Analyst

Robert Wasserman is an analyst at Benchmark. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 10/31/2024

Overall Average Return

-%

Smart Score

15%

Overall Average Return Percentile

-

Number of Ratings

106
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Unveiling 12 Analyst Insights On Halozyme Therapeutics
Analyst Scoreboard: 8 Ratings For Integer Holdings
What 8 Analyst Ratings Have To Say About Integer Holdings
Critical Insights From Ligand Pharmaceuticals Analyst Ratings: What You Need To Know
Assessing Ligand Pharmaceuticals: Insights From 7 Financial Analysts
A Glimpse Into The Expert Outlook On Halozyme Therapeutics Through 12 Analysts
The Latest Analyst Ratings For Ligand Pharmaceuticals
Navigating 6 Analyst Ratings For Integer Holdings
Critical Insights From Halozyme Therapeutics Analyst Ratings: What You Need To Know
This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved